Clinical trial · Observational
Study of Small Bowel Tumor With Dual-phase Enhanced Computed Tomography (CTE) and Magnetic Resonance Enterography (MRE)
A Prospective Comparison of Diagnostic Efficacy and Radiomics Study in the Diagnosis and Therapeutic Efficacy Evaluation of Small Bowel Tumor With Dual-phase Enhanced Computed Tomography (CTE) and Magnetic Resonance Enterography (MRE)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Purpose: To compare the accuracies of computed tomographic (CT) enterography and magnetic resonance (MR) enterography for the detection and radiomics characterization of small-bowel tumors (including gastrointestinal stromal tumors, adenomas and lymphomas, etc); Hypothesis: MR enterography was noninferior to CT enterography for the diagnosis and evaluation of small bowel tumors in generally well-distended small bowel.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Intestinal Neoplasms | Intestinal Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- A-first CTE examination
- label
- B-first MRE examination
Primary outcomes (1)
- measure
- the size in centimeters
- timeFrame
- through study completion, an average of 3 years, the size of the small bowel tumor will be reported.
- description
- the size of the small bowel tumor
Secondary outcomes (3)
- measure
- volume in cm^3
- timeFrame
- through study completion, an average of 3 years
- description
- the volume of the small bowel tumor
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients with clinical suspicion of small intestinal neoplasms and prescribed CTE and/or MRE examinations; * Age/sex: unlimited; * Patients with no severe heart, liver, kidney insufficiency; * Patients who voluntarily participate in clinical trials and sign written informed consent. Exclusion Criteria: * patients with heart and liver insufficiency; * patients with pacemakers installed and which materials are unknown, and patients with metal implants in the body, and nerve stimulators; * patients who are allergic to iodine and intestinal contrast agents; * pregnant women, patients with acute or chronic renal failure and hemodynamic instability; * patients unable to tolerate adequate breath holding for complete CT or MR examination; * patients who can not maintain compliance and cannot strictly implement the plan.
References
Publications (0)
Data not yet available